Antithrombotic Therapy

Author(s): W. L. Duvall

Journal Name: Current Molecular Medicine

Volume 6 , Issue 5 , 2006

Become EABM
Become Reviewer
Call for Editor


Coronary heart disease is the leading cause of death in the US and the industrialized world. Ever since DeWood in 1980 demonstrated that a thrombus was the primary event leading to acute myocardial infarction and that they may subsequently lyse, the mainstay of therapy for the past 25 years has been antithrombotic therapy aimed at coronary thrombosis. There have been numerous advances in the treatment of acute coronary syndrome with antiplatelet, antithrombotic, and fibrinolytic agents that have significantly reduced morbidity and mortality. The role of various pharmaceutical agents in the different phases of acute coronary syndrome is a complex and ever changing field.

Keywords: Antithrombotic therapy, myocardial infarction, acute coronary syndrome

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [603 - 619]
Pages: 17
DOI: 10.2174/156652406778018716
Price: $65

Article Metrics

PDF: 1